Loiasis (eye worm disease) - Causes, Treatment & When to See a Doctor

```html

What is Loiasis (eye worm disease)?

Loiasis, commonly known as “eye worm disease,” is a parasitic infection caused by the filarial nematode Loa loa. The adult worms live in the sub‑cutaneous tissue of humans and migrate through the body, sometimes crossing the conjunctiva of the eye, which creates the striking visual sign that gave the disease its nickname. Loiasis is endemic to the tropical rainforests of West and Central Africa, where the vector – the forest‑dwelling horse‑fly of the genus Chrysops – thrives.

Most infected people experience only mild, intermittent symptoms, but a minority develop serious complications such as ocular inflammation, skin swelling (angio‑edema), or even neurologic involvement when large numbers of micro‑filariae (larval stage) circulate in the bloodstream.

Because the disease is rare outside endemic areas, clinicians in non‑tropical regions may overlook it, leading to delayed diagnosis. Understanding the lifecycle, risk factors, and clinical presentation is essential for early recognition and appropriate care.

Common Causes

Loiasis is not caused by lifestyle choices or medications; it is acquired through exposure to infected vectors. The following factors increase the risk of infection:

• Living or traveling in endemic zones: Rural or forested areas of Cameroon, Central African Republic, Democratic Republic of the Congo, Gabon, Nigeria, and Equatorial Guinea.
• Outdoor occupations: Farming, logging, hunting, or mining where exposure to Chrysops flies is high.
• Night‑time exposure: Although Chrysops bite during the day, people who work or rest outdoors in the late afternoon are at greater risk.
• Inadequate protective clothing: Short sleeves, shorts, and lack of insect repellent increase bite chances.
• Recent travel to endemic regions: Even a single 2‑hour jungle trek can result in infection.
• Living near rivers or swamps: The breeding sites of the horse‑fly are often riparian.
• Previous filarial infections: Co‑infection with other filarial parasites (e.g., Onchocerca volvulus) can complicate immune responses.
• Genetic susceptibility: Some studies suggest certain HLA types may affect the intensity of micro‑filaremia (still under investigation).
• Absence of community‑wide vector control programs: Lack of insecticide‑treated nets or fly‑traps in rural villages.
• Poor access to preventive chemotherapy: Mass drug administration (MDA) programs for other filarial diseases rarely target Loa loa because of the risk of severe adverse reactions to ivermectin in heavily infected individuals.

Associated Symptoms

The clinical picture of loiasis is highly variable. Many people remain asymptomatic, while others experience a constellation of signs that tend to appear in “waves” as adult worms migrate.

• Calabar swellings: Transient, painful, pruritic sub‑cutaneous edemas, typically on the limbs or face, lasting from a few minutes to several days.
• Eye involvement: Live adult worm visible crossing the conjunctiva (often described as a “worm in the eye”). Patients may report itching, tearing, or a sensation of something moving.
• Dermatologic signs: Rashes, itching, or eczematous changes at bite sites.
• Systemic symptoms: Low‑grade fever, malaise, headache, and occasional muscle aches.
• Peripheral eosinophilia: Elevated eosinophil count on routine blood work, reflecting a parasitic immune response.
• Hyper‑reactive skin: In heavily infected individuals, even minor trauma can trigger exaggerated swelling (so‑called “loiasis‑associated angio‑edema”).
• Neurologic manifestations (rare): Seizures, transient ischemic attacks, or stroke‑like events when high micro‑filaremia leads to emboli in cerebral vessels.
• Renal involvement (very rare): Glomerulonephritis reported in a handful of case series.

When to See a Doctor

Because loiasis can mimic other tropical or allergic conditions, prompt medical evaluation is essential when any of the following occur:

• Visible worm moving across or under the surface of the eye.
• Recurrent, painful Calabar swellings, especially if they last longer than 48 hours.
• Fever, severe headache, or neurological symptoms (e.g., weakness, visual loss, seizures) after travel to an endemic area.
• Sudden, unexplained eye pain, redness, or vision changes.
• Persistent itching or rash that does not improve with antihistamines.
• A history of travel to endemic regions within the past 12 months combined with any of the above signs.

Early evaluation reduces the risk of complications and allows for safe selection of antiparasitic therapy.

Diagnosis

Diagnosing loiasis relies on a combination of clinical suspicion, travel history, and laboratory confirmation.

1. Clinical assessment

• Detailed travel and exposure history.
• Physical examination focusing on skin swellings and ocular inspection (slit‑lamp exam if needed).

2. Laboratory tests

• Peripheral blood smear (taken during daytime when micro‑filariae are present in the bloodstream) – stained with Giemsa; shows motile Loa loa larvae.
• Micro‑filarial density (MFD) count – quantified as number of micro‑filariae per milliliter of blood; guides treatment decisions because high loads (>30,000 mf/mL) increase risk of severe reactions to diethylcarbamazine (DEC) or ivermectin.
• Complete blood count (CBC) – eosinophilia (>500 cells/µL) supports a parasitic infection.
• Serologic tests – ELISA or rapid diagnostic tests detecting anti‑Loa antibodies; useful when micro‑filaremia is low.

3. Imaging (rarely needed)

• Ultrasound of the eye or sub‑cutaneous tissue may visualize adult worms.
• MRI/CT only if neurologic complications are suspected.

4. Community‑level screening

In endemic regions, mass screening programs use finger‑prick blood spots and rapid tests to identify high‑risk individuals before mass drug administration for other filarial diseases.

Treatment Options

Therapy aims to eliminate adult worms, reduce micro‑filaremia, and relieve symptoms, while minimizing the risk of severe adverse reactions.

Medical Treatment

• Diethylcarbamazine (DEC) 6 mg/kg/day divided into three doses for 12 days is the drug of choice for clearing both adult worms and micro‑filariae. Note: DEC is contraindicated in patients with high micro‑filarial loads (>30,000 mf/mL) because of the risk of severe encephalopathy.
• Ivermectin – single dose of 150–200 µg/kg is sometimes used for individuals with low micro‑filaremia when DEC is unavailable, but it primarily targets micro‑filariae and offers limited effect on adult worms.
• Albendazole 400 mg twice daily for 21 days – used as adjunct therapy in heavily infected patients; it reduces micro‑filarial burden before DEC can be safely administered.
• Corticosteroids (e.g., prednisone 0.5 mg/kg) – administered before DEC in patients with high micro‑filarial loads or severe Calabar swelling to blunt inflammatory reactions.
• Topical antibiotics or lubricants – for secondary bacterial conjunctivitis if the worm has breached the conjunctiva.

Symptomatic & Home Care

• Cold compresses on Calabar swellings to reduce pain and edema.
• Antihistamines (cetirizine, loratadine) for itching.
• Analgesics such as acetaminophen or ibuprofen for fever and discomfort.
• Eye irrigation with sterile saline if a worm is visible but not removable; do not attempt to pull the worm out yourself.
• Maintain hydration and a balanced diet to support the immune system.

Follow‑up

Repeat blood smears 1‑2 months after treatment to confirm clearance of micro‑filariae. Persistent eosinophilia may warrant additional therapy cycles.

Prevention Tips

Because loiasis is vector‑borne, prevention focuses on avoiding Chrysops bites and reducing environmental exposure.

• Wear protective clothing: Long‑sleeved shirts, long pants, and socks when outdoors.
• Use insect repellent: Products containing DEET (≥30 %), picaridin, or IR3535 applied to exposed skin and clothing.
• Stay under screened shelters: Tents or huts with fine mesh during daytime forest activities.
• Apply permethrin to clothing: Repels biting flies for up to 6 weeks.
• Avoid peak biting times: Early morning and late afternoon are high‑risk periods for Chrysops bites.
• Environmental control: In endemic villages, community programs that clear vegetation near dwellings and use insecticide‑treated nets (although Chrysops are day‑biters, nets can protect during naps).
• Pre‑travel consultation: Discuss prophylactic measures with a travel medicine specialist before visiting endemic regions.
• Screening of travelers returning from endemic zones: If symptoms develop within a year, seek prompt evaluation.

Emergency Warning Signs

Key Take‑aways

• Loiasis is a tropical filarial infection transmitted by day‑biting horse‑flies; the hallmark sign is a live worm crossing the eye.
• Most infections are mild, but high micro‑filaremia can trigger serious reactions to treatment and rare neurologic complications.
• Diagnosis hinges on daytime blood smears, eosinophilia, and a clear travel history.
• Diethylcarbamazine is the mainstay treatment, but must be used cautiously in heavily infected patients.
• Prevention relies on bite avoidance—proper clothing, repellents, and environmental control.
• Urgent medical attention is required for ocular involvement, severe swelling, neurologic signs, or any rapid systemic deterioration.

For the most up‑to‑date information, consult reputable sources such as the CDC, Mayo Clinic, and the World Health Organization.

```